China’s Growing Involvement in Global Health Governance; Contributions and Implications
DOI:
https://doi.org/10.15642/sarpass.2021.1.1.1-14Keywords:
Covid-19, Global Health Governance, Global Health CommunityAbstract
The outbreak of the COVID-19 global pandemic has exposed deficiencies in global health governance. China has been active in making intellectual and material contributions to the global fight against COVID-19 while achieving significant progress in containing the epidemic domestically. China’s contribution to global cooperation in the fight against the virus can be reflected in: (1) China has actively shared its experience in COVID-19 control and the treatment of infected cases with the international community; (2) China has sent 37 medical expert teams to help improve measures of diagnosis, treatment, prevention and control in 34 countries as of July 2021; (3) China has done its best to provide medical supplies to more than 150 countries and 13 international organizations as of July 2021; (4) China has made efforts to make vaccine accessible and affordable in developing countries. The implications of China’s involvement in global health governance include: (1) advocating the concept of “building a global community of health for all”; (2) supporting the leadership role of the World Health Organization in global health governance; (3) improving the global health governance system and WHO’s ability; and (4) cultivating public health talent with knowledge of international rules and diplomatic skills.Downloads
References
Allen, John R., Nicholas Burns, Laurie Garrett, Richard N. Haass, G. John Ikenberry, Kishore Mahbubani, Shivshankar Menon, Robin Niblett, Joseph S. Nye Jr., Shannon K. O’Neil, Kori Schake, & Stephen M. Walt. (2020). How the World Will Look After the Coronavirus Pandemic. Retrieved August 10, 2020, from https://foreignpolicy.com/2020/03/20/world-order-after-coroanvirus-pandemic/
Bieber, Florian. (2020). Global Nationalism in Times of the COVID-19 Pandemic. Nationalities Papers. https://doi.org/10.1017/nps.2020.35.
Cctv.com. (2021). China International Development Cooperation Agency: China’s COVID-19 Aid Benefits more than 150 Countries. Retrieved from http://m.news.cctv.com/2021/07/04/ARTIOp2jpg5qdS1oQeZkUkHb210704.shtml
Chinadaily.com.cn. (2020). China in Words: Global Community of Health for All from China Practice. Retrieved from http://www.chinadaily.com.cn/a/202006/29/WS5ef975ada310834817255d4d.html.
Chinanews.com. (2020). China’s Third Medical Team to Italy Returns China Safely. Retrieved from http://www.chinanews.com/gn/2020/04-09/9152076.shtml
Chinese Ministry of Foreign Affairs. (2020). Foreign Ministry Spokesperson Hua Chunying’s Remarks on China Joining COVAX. Retrieved from https://www.fmprc.gov.cn/mfa_eng/xwfw_665399/s2510_665401/2535_665405/t1822631.shtml.
Chinese Ministry of Foreign Affairs. (2021a). President Xi Jinping Sends Message to the First Meeting of the International Forum on COVID-19 Vaccine Cooperation. Retrieved from, https://www.fmprc.gov.cn/mfa_eng/zxxx_662805/t1897887.shtml.
Chinese Ministry of Foreign Affairs. (2021b). Wang Yi Hosts the First Meeting of the International Forum on COVID-19 Vaccine Cooperation. Retrieved from, https://www.fmprc.gov.cn/mfa_eng/zxxx_662805/t1897844.shtml.
Fidler, David P. (2010). The Challenges of Global Health Governance. Council on Foreign Relations Working Paper. https://www.cfr.org/report/challenges-global-health-governance.
Gavi. (n.d.). What is COVAX?. Retrieved from https://www.gavi.org/covax-facility#what.
Genevaz, Juliette. (2021). “China’s Place in Global Health Governance”. EURICS Briefs, No. 9.
Gopinath, Gita. (2020). The Great Lockdown: Worst Economic Downturn since the Great Depression. Retrieved from https://blogs.imf.org/2020/04/14/the-great-lockdown-worst-economic-downturn-since-the-great-depression/.
Gostin, Lawrence O., Harold Hongju Koh, Michelle Williams, et al. (2020a). US Withdrawal from the WHO is Unlawful and Threatens Global and US Health and Security. Lancet, Vol.396 Issue 10247. https://doi.org/10.1016/S0140-6736(20)31527-0
Gostin, Lawrence O., Suerie Moon, & Benjamin Mason Meier. (2020b). “Reimagining Global Health Governance in the Age of COVID-19”. American Journal of Public Health, Vol.110 No.11.
Han, Tieru. (2020). “The Challenges for WHO’s Global Health Governance”. The Journal of International Studies, Vol. 41 No. 3.
HHRDC of the NHC. (2020). Health Human Resources Development Center of the National Health Commission Launches the Knowledge Center for China’s Experiences in Response to COVID-19. Retrieved from https://www.21wecan.com/gjhznew/rdxw_1213/202003/t20200331_8658.html
IMF. (2021). World Economic Outlook: Managing Divergent Recoveries. Retrieved from https://www.imf.org/en/Publications/WEO/Issues/2021/03/23/world-economic-outlook-april-2021.
Jin, Jiyong. (2020). “COVID-19, WHO Reform and Global Governance”. Foreign Affairs Review, Vol.37 No.3.
Klippe, Nathan Vander. (2020). Huawei Sending Millions of Masks to Canada as Supplies Grow Short. Retrieved from https://www.theglobeandmail.com/world/article-huawei-sending-millions-of-masks-to-canada-as-supplies-grow-short/.
Kohl, Katrin S., Arthur, Ray R., O’Connor, Ralph, & Fernandez, Jose. (2012). “Assessment of Public Health Events through International Health Regulations, United States, 2007–2011”. Emerging Infectious Diseases, Vol.18 No.7.
Liu, Tiewa. (2021). “The Central Position and Challenges of World Health Organization in Global Health Governance”. Pacific Journal, Vol.29 No.2.
Ma, Xiaowei. (2020). Deepen International Cooperation to Combat COVID-19 and Build a Global Community of Health for All. Quishi Journal, No.8. http://en.qstheory.cn/2020-07/15/c_524055.htm.
Ma, Xuejiao, Wei Ding, Yingjun Qian, Shenning Lu, Bei Wang, Qiuli Xu, Duoquan Wang, Yayi Guan, Ning Xiao, & Xiaonong Zhou. (2021). “Deployment of Workforce in Global Health: What Should be the Priorities for China?”. Global Health Research and Policy, Vol.6 No.22.
McCarthy, Niall. (2020). Which Countries are the Biggest Financial Contributors to the World Health Organization?. Retrieved from, https://www.forbes.com/sites/niallmccarthy/2020/04/08/which-countries-are-the-biggest-financial-contributors-to-the-world-health-organization-infographic/?sh=7e73146c494c.
New York State Government. (2020). Governor Cuomo Announces Significant Donations to Help Increase The State’s Supply Capacity Amid Ongoing COVID-19 Pandemic. Retrieved from https://www.governor.ny.gov/news/governor-cuomo-announces-significant-donations-help-increase-states-supply-capacity-amid.
Qu, Pengfei. (2020, August 21). Handling Risks and Challenges, and Improving the Global Health Governance. Retrieved from Study Times.
Tang, Bei. (2020). “The PHEIC Regime and the Evolution of the World Health Organization’s Role”. World Economics and Politics, No.3.
The State Council Information Office of China. (2020). Fighting COVID-19: China in Action. Retrieved from http://www.scio.gov.cn/ztk/dtzt/42313/43142/index.htm.
UNEP. (n.d.). Secretariats and Conventions. Retrieved August 6, 2021, from https://www.unep.org/about-un-environment/why-does-un-environment-matter/secretariats-and-conventions.
Wang, Zhaoxin, Jianwei Shi, Gang Xu, Yong Cai, & Hui Wang. (2020). “Analysis on Bottleneck and Prospect of Outstanding Public Health Talents Training in China”. Bulletin of Chinese Academy of Sciences, Vol.35 No.3.
WHO. (2013). WHO’s Role in Global Health Governance: Report by the Director-General, EB 132/5 Add. 5. https://apps.who.int/gb/ebwha/pdf_files/EB132/B132_5Add5-en.pdf.
WHO (2021a). WHO Coronavirus (COVID-19) Dashboard. Retrieved July 5, 2021, from https://covid19.who.int/?gclid=EAIaIQobChMIi7fvroXO8QIVQ7eWCh0Whwk6EAAYASABEgLDmPD_BwE,%20accessed%20on%205%20July%202021.
WHO. (2021b). COVID-19 Vaccine for Emergency Use and Issues Interim Policy Recommendations. Retrieved from https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations.
WHO. (2021c). WHO Validates Sinovac COVID-19 Vaccine for Emergency Use and Issues Interim Policy Recommendations. Retrieved from https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations.
WHO. (n.d.). Assessed Contributions Payable by Member States and Associate Members 2020-2021. Retrieved August 6, 2021, from https://www.who.int/about/finances-accountability/funding/2020-21_AC_Summary.pdf?ua=1.
Xinhua. (2020a). China Publishes Timeline on COVID-19 Information Sharing Int’l Cooperation. Retrieved from http://www.xinhuanet.com/english/2020-04/06/c_138951662.htm.
Xinhua. (2020b). China’s COVID-19 Vaccine to Become Global Public Good when Available: Xi. Retrieved from http://www.xinhuanet.com/english/2020-05/18/c_139066851.htm.
Xinhua. (2020c). Xi Jinping Delivers a Speech at a Meeting Commending Role Models in China’s Fight against the COVID-19 Epidemic. Retrieved from http://www.xinhuanet.com/politics/2020-09/08/c_1210790162.htm
Youde, Jeremy. (2010). Biopolitical Surveillance and Public Health in International Politics. New York: Palgrave Macmilan.
Yuan, Peng. (2020). “The COVID-19 Pandemic and Changes Unseen in a Century”. Contemporary International Relations, No.4.
Zhang, Guihong, & Wang, Yue. (2020). “On Main Characteristics of China’s Diplomacy toward International Organizations: A Case Study of China’s Diplomacy toward World Health Organization”. International Review, No.4.
Zhang, Haibin. (2020). “Global Health Governance Reform in the Context of First-Level Public Health Emergencies: A Preliminary Analysis”. The Journal of International Studies, Vol.41 No.3.
Zhang, Qingmin. (2020). “COVID-19 Tests Global Health Governance”. Northeast Asia Forum, No.4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Huaigao Qi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
